Jamie Young v. HHS - Tdap, transverse myelitis (2023)
Case summary [AI summaries can sometimes make mistakes]
On June 9, 2021, Jamie Young filed a petition in the National Vaccine Injury Compensation Program alleging that she suffered from transverse myelitis (TM) as a result of receiving a Tdap vaccine on June 18, 2018. Petitioner further alleged that she experienced residual effects from this injury for more than six months.
The respondent denied that the Tdap vaccine caused Petitioner's TM or its residual effects, and denied that the vaccine caused any other injury or Petitioner's current condition. Despite maintaining their respective positions, both parties agreed to settle the case through a stipulation filed on September 5, 2023.
Chief Special Master Brian H. Corcoran reviewed the stipulation and found it to be reasonable, adopting it as the decision of the court.
The stipulation awarded Jamie Young a lump sum of $25,000.00, representing compensation for all damages available under the National Childhood Vaccine Injury Act of 1986. The court directed that judgment be entered accordingly.
Theory of causation
Petitioner Jamie Young alleged that she suffered from transverse myelitis (TM) and its residual effects for more than six months as a result of receiving a Tdap vaccine on June 18, 2018. Respondent denied that the Tdap vaccine caused Petitioner's TM or its residual effects. The parties reached a settlement stipulation, filed September 5, 2023, agreeing to an award of compensation. Chief Special Master Brian H. Corcoran reviewed the stipulation and adopted it as the decision of the court. The stipulation awarded Jamie Young $25,000.00 as compensation for all damages available under the Act. The public decision does not describe the specific theory of causation, medical experts, onset, symptoms, tests, or treatments.
Source PDFs
USCOURTS-cofc-1_21-vv-01453